Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Top Cited Papers
- 1 May 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (5), 812-819
- https://doi.org/10.1161/atvbaha.107.159327
Abstract
The initiation of atherosclerosis results from complex interactions of circulating factors and various cell types in the vessel wall, including endothelial cells, lymphocytes, monocytes, and smooth muscle cells (SMCs). Recent reviews highlight the role of activated endothelium and inflammatory cell recruitment in the initiation of and progression of early atherosclerosis. Yet, human autopsy studies, in vitro mechanistic studies, and in vivo correlative data suggest an important role for SMCs in the initiation of atherosclerosis. SMCs are the major producers of extracellular matrix within the vessel wall and in response to atherogenic stimuli can modify the type of matrix proteins produced. In turn, the type of matrix present can affect the lipid content of the developing plaque and the proliferative index of the cells that are adherent to it. SMCs are also capable of functions typically attributed to other cell types. Like macrophages, SMCs can express a variety of receptors for lipid uptake and can form foam-like cells, thereby participating in the early accumulation of plaque lipid. Like endothelial cells, SMCs can also express a variety of adhesion molecules such as vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 to which monocytes and lymphocytes can adhere and migrate into the vessel wall. In addition, through these adhesion molecules, SMCs can also stabilize these cells against apoptosis, thus contributing to the early cellularity of the lesion. Like many cells within the developing plaque, SMCs also produce many cytokines such as PDGF, transforming growth factor-β, IFNγ, and MCP-1, all of which contribute to the initiation and propagation of the inflammatory response to lipid. Recent advances in SMC-specific gene modulation have enhanced our ability to determine the role of SMCs in early atherogenesis. Smooth muscle cells (SMCs) play a key role in fibrous cap formation and plaque stability in advanced atherosclerosis; however, less is known about the role of SMCs in the initiation and progression of atherosclerosis. This review summarizes the present data implicating SMCs in the development of early atherogenesis.Keywords
This publication has 103 references indexed in Scilit:
- Smooth Muscle–Targeted Knockout of Connexin43 Enhances Neointimal Formation in Response to Vascular InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- PPARγ activation induces CD36 expression and stimulates foam cell like changes in rVSMCsProstaglandins & Other Lipid Mediators, 2006
- The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon γBiochemical and Biophysical Research Communications, 2004
- Progression of AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Proliferation and the Monoclonal Origins of Atherosclerotic LesionsAnnual Review of Medicine, 1998
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotypeDevelopmental Biology, 1989
- Study of coronary intimal thickeningAtherosclerosis, 1985
- Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellSBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981